APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastric Cancer Diagnostic Procedure

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gastric Cancer Diagnostic Procedure Market Outlook and Growth Opportunities 2026

5 March 2026208 pages

Choose your research edition.

Industry ResearchGastric Cancer Diagnostic Procedure Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastric Cancer Diagnostic Procedure Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Gastric Cancer Diagnostic Procedure Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastric Cancer Diagnostic Procedure Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastric Cancer Diagnostic Procedure Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Gastric Cancer Diagnostic Procedure market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gastric Cancer Diagnostic Procedure is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gastric Cancer Diagnostic Procedure is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastric Cancer Diagnostic Procedure is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gastric Cancer Diagnostic Procedure market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gastric Cancer Diagnostic Procedure market include Pfizer Inc., Johnson & Johnson Co, F.Hoffmann La Roche, Merck & Co. Ilnc, Bayer AG, Novartis AG, Bristol-Myers Squibb Company, ThermoFisher Scientific Inc and AstraZeneca plc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Gastric Cancer Diagnostic Procedure market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gastric Cancer Diagnostic Procedure and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gastric Cancer Diagnostic Procedure revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Gastric Cancer Diagnostic Procedure market.

Gastric Cancer Diagnostic Procedure Segment by Company

Pfizer Inc.

Johnson & Johnson Co

F.Hoffmann La Roche

Merck & Co. Ilnc

Bayer AG

Novartis AG

Bristol-Myers Squibb Company

ThermoFisher Scientific Inc

AstraZeneca plc

Abbott Laboratories Inc

Sanof SA

Eli Lilly and Company

OtsukaPharmaceutical Co Ltd

AdventHealth, Atrium Health

Astellas Pharma Inc

Bausch Health Companies Inc

Gastric Cancer Diagnostic Procedure Segment by Type

Instrument

Test Strips and Consumables

Service

Gastric Cancer Diagnostic Procedure Segment by Application

Early Gastric Cancer

Advanced Gastric Cancer

Gastric Cancer Diagnostic Procedure Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gastric Cancer Diagnostic Procedure status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Gastric Cancer Diagnostic Procedure key companies, revenue, market share, and recent developments.

3. To split the Gastric Cancer Diagnostic Procedure breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Gastric Cancer Diagnostic Procedure market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gastric Cancer Diagnostic Procedure significant trends, drivers, influence factors in global and regions.

6. To analyze Gastric Cancer Diagnostic Procedure competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastric Cancer Diagnostic Procedure market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastric Cancer Diagnostic Procedure and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastric Cancer Diagnostic Procedure.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gastric Cancer Diagnostic Procedure industry.

Chapter 3: Detailed analysis of Gastric Cancer Diagnostic Procedure company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Gastric Cancer Diagnostic Procedure in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Gastric Cancer Diagnostic Procedure in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gastric Cancer Diagnostic Procedure Industry Trends Table 2. Gastric Cancer Diagnostic Procedure Industry Drivers Table 3. Gastric Cancer Diagnostic Procedure Industry Opportunities and Challenges Table 4. Gastric Cancer Diagnostic Procedure Industry Restraints Table 5. Global Gastric Cancer Diagnostic Procedure Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gastric Cancer Diagnostic Procedure Revenue Share by Company (2021-2026) Table 7. Global Gastric Cancer Diagnostic Procedure Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Gastric Cancer Diagnostic Procedure Key Company Manufacturing Base & Headquarters Table 9. Global Gastric Cancer Diagnostic Procedure Company, Product Type & Application Table 10. Global Gastric Cancer Diagnostic Procedure Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Gastric Cancer Diagnostic Procedure by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Instrument Table 15. Significant Companies of Test Strips and Consumables Table 16. Significant Companies of Service Table 17. Global Gastric Cancer Diagnostic Procedure Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Gastric Cancer Diagnostic Procedure Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Gastric Cancer Diagnostic Procedure Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Gastric Cancer Diagnostic Procedure Sales Value Share by Type (2021-2026) Table 21. Global Gastric Cancer Diagnostic Procedure Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Early Gastric Cancer Table 23. Significant Companies of Advanced Gastric Cancer Table 24. Global Gastric Cancer Diagnostic Procedure Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Gastric Cancer Diagnostic Procedure Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Gastric Cancer Diagnostic Procedure Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Gastric Cancer Diagnostic Procedure Sales Value Share by Application (2021-2026) Table 28. Global Gastric Cancer Diagnostic Procedure Sales Value Share by Application (2027-2032) Table 29. Global Gastric Cancer Diagnostic Procedure Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Gastric Cancer Diagnostic Procedure Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Gastric Cancer Diagnostic Procedure Sales Value Share by Region (2021-2026) Table 32. Global Gastric Cancer Diagnostic Procedure Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Gastric Cancer Diagnostic Procedure Sales Value Share by Region (2027-2032) Table 34. Global Gastric Cancer Diagnostic Procedure Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Gastric Cancer Diagnostic Procedure Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Gastric Cancer Diagnostic Procedure Sales Value Market Share by Country (2021-2026) Table 37. Global Gastric Cancer Diagnostic Procedure Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Gastric Cancer Diagnostic Procedure Sales Value Market Share by Country (2027-2032) Table 39. Pfizer Inc. Company Information Table 40. Pfizer Inc. Business Overview Table 41. Pfizer Inc. Gastric Cancer Diagnostic Procedure Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Pfizer Inc. Gastric Cancer Diagnostic Procedure Product Portfolio Table 43. Pfizer Inc. Recent Development Table 44. Johnson & Johnson Co Company Information Table 45. Johnson & Johnson Co Business Overview Table 46. Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Product Portfolio Table 48. Johnson & Johnson Co Recent Development Table 49. F.Hoffmann La Roche Company Information Table 50. F.Hoffmann La Roche Business Overview Table 51. F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Product Portfolio Table 53. F.Hoffmann La Roche Recent Development Table 54. Merck & Co. Ilnc Company Information Table 55. Merck & Co. Ilnc Business Overview Table 56. Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Product Portfolio Table 58. Merck & Co. Ilnc Recent Development Table 59. Bayer AG Company Information Table 60. Bayer AG Business Overview Table 61. Bayer AG Gastric Cancer Diagnostic Procedure Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Bayer AG Gastric Cancer Diagnostic Procedure Product Portfolio Table 63. Bayer AG Recent Development Table 64. Novartis AG Company Information Table 65. Novartis AG Business Overview Table 66. Novartis AG Gastric Cancer Diagnostic Procedure Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Novartis AG Gastric Cancer Diagnostic Procedure Product Portfolio Table 68. Novartis AG Recent Development Table 69. Bristol-Myers Squibb Company Company Information Table 70. Bristol-Myers Squibb Company Business Overview Table 71. Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Product Portfolio Table 73. Bristol-Myers Squibb Company Recent Development Table 74. ThermoFisher Scientific Inc Company Information Table 75. ThermoFisher Scientific Inc Business Overview Table 76. ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Product Portfolio Table 78. ThermoFisher Scientific Inc Recent Development Table 79. AstraZeneca plc Company Information Table 80. AstraZeneca plc Business Overview Table 81. AstraZeneca plc Gastric Cancer Diagnostic Procedure Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. AstraZeneca plc Gastric Cancer Diagnostic Procedure Product Portfolio Table 83. AstraZeneca plc Recent Development Table 84. Abbott Laboratories Inc Company Information Table 85. Abbott Laboratories Inc Business Overview Table 86. Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Product Portfolio Table 88. Abbott Laboratories Inc Recent Development Table 89. Sanof SA Company Information Table 90. Sanof SA Business Overview Table 91. Sanof SA Gastric Cancer Diagnostic Procedure Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Sanof SA Gastric Cancer Diagnostic Procedure Product Portfolio Table 93. Sanof SA Recent Development Table 94. Eli Lilly and Company Company Information Table 95. Eli Lilly and Company Business Overview Table 96. Eli Lilly and Company Gastric Cancer Diagnostic Procedure Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Eli Lilly and Company Gastric Cancer Diagnostic Procedure Product Portfolio Table 98. Eli Lilly and Company Recent Development Table 99. OtsukaPharmaceutical Co Ltd Company Information Table 100. OtsukaPharmaceutical Co Ltd Business Overview Table 101. OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Product Portfolio Table 103. OtsukaPharmaceutical Co Ltd Recent Development Table 104. AdventHealth, Atrium Health Company Information Table 105. AdventHealth, Atrium Health Business Overview Table 106. AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Product Portfolio Table 108. AdventHealth, Atrium Health Recent Development Table 109. Astellas Pharma Inc Company Information Table 110. Astellas Pharma Inc Business Overview Table 111. Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Product Portfolio Table 113. Astellas Pharma Inc Recent Development Table 114. Bausch Health Companies Inc Company Information Table 115. Bausch Health Companies Inc Business Overview Table 116. Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Product Portfolio Table 118. Bausch Health Companies Inc Recent Development Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Gastric Cancer Diagnostic Procedure Product Image Figure 2. Global Gastric Cancer Diagnostic Procedure Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastric Cancer Diagnostic Procedure Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Instrument Image Figure 8. Test Strips and Consumables Image Figure 9. Service Image Figure 10. Global Gastric Cancer Diagnostic Procedure Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Gastric Cancer Diagnostic Procedure Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Gastric Cancer Diagnostic Procedure Sales Value Share by Type (2021-2032) Figure 13. Early Gastric Cancer Image Figure 14. Advanced Gastric Cancer Image Figure 15. Global Gastric Cancer Diagnostic Procedure Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Gastric Cancer Diagnostic Procedure Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Gastric Cancer Diagnostic Procedure Sales Value Share by Application (2021-2032) Figure 18. Global Gastric Cancer Diagnostic Procedure Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Gastric Cancer Diagnostic Procedure Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Gastric Cancer Diagnostic Procedure Sales Value (2021-2032) & (US$ Million) Figure 21. North America Gastric Cancer Diagnostic Procedure Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Gastric Cancer Diagnostic Procedure Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Gastric Cancer Diagnostic Procedure Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Gastric Cancer Diagnostic Procedure Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Gastric Cancer Diagnostic Procedure Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Gastric Cancer Diagnostic Procedure Sales Value (2021-2032) & (US$ Million) Figure 27. South America Gastric Cancer Diagnostic Procedure Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Gastric Cancer Diagnostic Procedure Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Gastric Cancer Diagnostic Procedure Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Instrument
  • Test Strips and Consumables
  • Service
Applications
  • Early Gastric Cancer
  • Advanced Gastric Cancer
Companies covered
  • Pfizer Inc.
  • Johnson & Johnson Co
  • F.Hoffmann La Roche
  • Merck & Co. Ilnc
  • Bayer AG
  • Novartis AG
  • Bristol-Myers Squibb Company
  • ThermoFisher Scientific Inc
  • AstraZeneca plc
  • Abbott Laboratories Inc
  • Sanof SA
  • Eli Lilly and Company
  • OtsukaPharmaceutical Co Ltd
  • AdventHealth, Atrium Health
  • Astellas Pharma Inc
  • Bausch Health Companies Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gastric Cancer Diagnostic Procedure Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gastric Cancer Diagnostic Procedure Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Gastric Cancer Diagnostic Procedure Market Dynamics
  1. 2.1 Gastric Cancer Diagnostic Procedure Industry Trends
  2. 2.2 Gastric Cancer Diagnostic Procedure Industry Drivers
  3. 2.3 Gastric Cancer Diagnostic Procedure Industry Opportunities and Challenges
  4. 2.4 Gastric Cancer Diagnostic Procedure Industry Restraints
3 Gastric Cancer Diagnostic Procedure Market by Company
  1. 3.1 Global Gastric Cancer Diagnostic Procedure Company Revenue Ranking in 2025
  2. 3.2 Global Gastric Cancer Diagnostic Procedure Revenue by Company (2021-2026)
  3. 3.3 Global Gastric Cancer Diagnostic Procedure Company Ranking (2024-2026)
  4. 3.4 Global Gastric Cancer Diagnostic Procedure Company Manufacturing Base and Headquarters
  5. 3.5 Global Gastric Cancer Diagnostic Procedure Company Product Type and Application
  6. 3.6 Global Gastric Cancer Diagnostic Procedure Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Gastric Cancer Diagnostic Procedure Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Gastric Cancer Diagnostic Procedure Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Gastric Cancer Diagnostic Procedure Market by Type
  1. 4.1 Gastric Cancer Diagnostic Procedure Type Introduction
  2. 4.1.1 Instrument
  3. 4.1.2 Test Strips and Consumables
  4. 4.1.3 Service
  5. 4.2 Global Gastric Cancer Diagnostic Procedure Sales Value by Type
  6. 4.2.1 Global Gastric Cancer Diagnostic Procedure Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Gastric Cancer Diagnostic Procedure Sales Value by Type (2021-2032)
  8. 4.2.3 Global Gastric Cancer Diagnostic Procedure Sales Value Share by Type (2021-2032)
5 Gastric Cancer Diagnostic Procedure Market by Application
  1. 5.1 Gastric Cancer Diagnostic Procedure Application Introduction
  2. 5.1.1 Early Gastric Cancer
  3. 5.1.2 Advanced Gastric Cancer
  4. 5.2 Global Gastric Cancer Diagnostic Procedure Sales Value by Application
  5. 5.2.1 Global Gastric Cancer Diagnostic Procedure Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Gastric Cancer Diagnostic Procedure Sales Value by Application (2021-2032)
  7. 5.2.3 Global Gastric Cancer Diagnostic Procedure Sales Value Share by Application (2021-2032)
6 Gastric Cancer Diagnostic Procedure Regional Value Analysis
  1. 6.1 Global Gastric Cancer Diagnostic Procedure Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gastric Cancer Diagnostic Procedure Sales Value by Region (2021-2032)
  3. 6.2.1 Global Gastric Cancer Diagnostic Procedure Sales Value by Region: 2021-2026
  4. 6.2.2 Global Gastric Cancer Diagnostic Procedure Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gastric Cancer Diagnostic Procedure Sales Value (2021-2032)
  7. 6.3.2 North America Gastric Cancer Diagnostic Procedure Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Gastric Cancer Diagnostic Procedure Sales Value (2021-2032)
  10. 6.4.2 Europe Gastric Cancer Diagnostic Procedure Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Gastric Cancer Diagnostic Procedure Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Gastric Cancer Diagnostic Procedure Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Gastric Cancer Diagnostic Procedure Sales Value (2021-2032)
  16. 6.6.2 South America Gastric Cancer Diagnostic Procedure Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Gastric Cancer Diagnostic Procedure Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Gastric Cancer Diagnostic Procedure Sales Value Share by Country, 2025 VS 2032
7 Gastric Cancer Diagnostic Procedure Country-level Value Analysis
  1. 7.1 Global Gastric Cancer Diagnostic Procedure Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gastric Cancer Diagnostic Procedure Sales Value by Country (2021-2032)
  3. 7.2.1 Global Gastric Cancer Diagnostic Procedure Sales Value by Country (2021-2026)
  4. 7.2.2 Global Gastric Cancer Diagnostic Procedure Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Gastric Cancer Diagnostic Procedure Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Gastric Cancer Diagnostic Procedure Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Gastric Cancer Diagnostic Procedure Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer Inc.
  2. 8.1.1 Pfizer Inc. Company Information
  3. 8.1.2 Pfizer Inc. Business Overview
  4. 8.1.3 Pfizer Inc. Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Inc. Gastric Cancer Diagnostic Procedure Product Portfolio
  6. 8.1.5 Pfizer Inc. Recent Developments
  7. 8.2 Johnson & Johnson Co
  8. 8.2.1 Johnson & Johnson Co Company Information
  9. 8.2.2 Johnson & Johnson Co Business Overview
  10. 8.2.3 Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Product Portfolio
  12. 8.2.5 Johnson & Johnson Co Recent Developments
  13. 8.3 F.Hoffmann La Roche
  14. 8.3.1 F.Hoffmann La Roche Company Information
  15. 8.3.2 F.Hoffmann La Roche Business Overview
  16. 8.3.3 F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  17. 8.3.4 F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Product Portfolio
  18. 8.3.5 F.Hoffmann La Roche Recent Developments
  19. 8.4 Merck & Co. Ilnc
  20. 8.4.1 Merck & Co. Ilnc Company Information
  21. 8.4.2 Merck & Co. Ilnc Business Overview
  22. 8.4.3 Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Product Portfolio
  24. 8.4.5 Merck & Co. Ilnc Recent Developments
  25. 8.5 Bayer AG
  26. 8.5.1 Bayer AG Company Information
  27. 8.5.2 Bayer AG Business Overview
  28. 8.5.3 Bayer AG Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer AG Gastric Cancer Diagnostic Procedure Product Portfolio
  30. 8.5.5 Bayer AG Recent Developments
  31. 8.6 Novartis AG
  32. 8.6.1 Novartis AG Company Information
  33. 8.6.2 Novartis AG Business Overview
  34. 8.6.3 Novartis AG Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis AG Gastric Cancer Diagnostic Procedure Product Portfolio
  36. 8.6.5 Novartis AG Recent Developments
  37. 8.7 Bristol-Myers Squibb Company
  38. 8.7.1 Bristol-Myers Squibb Company Company Information
  39. 8.7.2 Bristol-Myers Squibb Company Business Overview
  40. 8.7.3 Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Product Portfolio
  42. 8.7.5 Bristol-Myers Squibb Company Recent Developments
  43. 8.8 ThermoFisher Scientific Inc
  44. 8.8.1 ThermoFisher Scientific Inc Company Information
  45. 8.8.2 ThermoFisher Scientific Inc Business Overview
  46. 8.8.3 ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Product Portfolio
  48. 8.8.5 ThermoFisher Scientific Inc Recent Developments
  49. 8.9 AstraZeneca plc
  50. 8.9.1 AstraZeneca plc Company Information
  51. 8.9.2 AstraZeneca plc Business Overview
  52. 8.9.3 AstraZeneca plc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca plc Gastric Cancer Diagnostic Procedure Product Portfolio
  54. 8.9.5 AstraZeneca plc Recent Developments
  55. 8.10 Abbott Laboratories Inc
  56. 8.10.1 Abbott Laboratories Inc Company Information
  57. 8.10.2 Abbott Laboratories Inc Business Overview
  58. 8.10.3 Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Product Portfolio
  60. 8.10.5 Abbott Laboratories Inc Recent Developments
  61. 8.11 Sanof SA
  62. 8.11.1 Sanof SA Company Information
  63. 8.11.2 Sanof SA Business Overview
  64. 8.11.3 Sanof SA Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sanof SA Gastric Cancer Diagnostic Procedure Product Portfolio
  66. 8.11.5 Sanof SA Recent Developments
  67. 8.12 Eli Lilly and Company
  68. 8.12.1 Eli Lilly and Company Company Information
  69. 8.12.2 Eli Lilly and Company Business Overview
  70. 8.12.3 Eli Lilly and Company Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Eli Lilly and Company Gastric Cancer Diagnostic Procedure Product Portfolio
  72. 8.12.5 Eli Lilly and Company Recent Developments
  73. 8.13 OtsukaPharmaceutical Co Ltd
  74. 8.13.1 OtsukaPharmaceutical Co Ltd Company Information
  75. 8.13.2 OtsukaPharmaceutical Co Ltd Business Overview
  76. 8.13.3 OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  77. 8.13.4 OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Product Portfolio
  78. 8.13.5 OtsukaPharmaceutical Co Ltd Recent Developments
  79. 8.14 AdventHealth, Atrium Health
  80. 8.14.1 AdventHealth, Atrium Health Company Information
  81. 8.14.2 AdventHealth, Atrium Health Business Overview
  82. 8.14.3 AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Product Portfolio
  84. 8.14.5 AdventHealth, Atrium Health Recent Developments
  85. 8.15 Astellas Pharma Inc
  86. 8.15.1 Astellas Pharma Inc Company Information
  87. 8.15.2 Astellas Pharma Inc Business Overview
  88. 8.15.3 Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Product Portfolio
  90. 8.15.5 Astellas Pharma Inc Recent Developments
  91. 8.16 Bausch Health Companies Inc
  92. 8.16.1 Bausch Health Companies Inc Company Information
  93. 8.16.2 Bausch Health Companies Inc Business Overview
  94. 8.16.3 Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Product Portfolio
  96. 8.16.5 Bausch Health Companies Inc Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst